+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Ischemic Agents - Global Strategic Business Report

  • PDF Icon

    Report

  • 94 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302221
The global market for Anti-Ischemic Agents is estimated at US$344.6 Million in 2023 and is projected to reach US$525.1 Million by 2030, growing at a CAGR of 6.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Regional Analysis: Gain insights into the U.S. market, estimated at $89.8 Million in 2023, and China, forecasted to grow at an impressive 9.6% CAGR to reach $125.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Anti-Ischemic Agents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Anti-Ischemic Agents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Anti-Ischemic Agents Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as AstraZeneca, Actelion, Bayer AG, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 43 Featured):

  • AstraZeneca
  • Actelion
  • Bayer AG
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Baxter, Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Anti-Ischemic Agents - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Anti-Ischemic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Anti-Ischemic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Anti-Ischemic Agents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 5: USA Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 6: USA Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
CANADA
  • Table 7: Canada Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 8: Canada Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
JAPAN
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 9: Japan Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 10: Japan Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
CHINA
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 11: China Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 12: China Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
EUROPE
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 13: Europe Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: Europe Historic Review for Anti-Ischemic Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: Europe 16-Year Perspective for Anti-Ischemic Agents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 16: France Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 17: France Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
GERMANY
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 18: Germany Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 19: Germany Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ITALY
  • Table 20: Italy Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: Italy Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
UNITED KINGDOM
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 22: UK Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 23: UK Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SPAIN
  • Table 24: Spain Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 25: Spain Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
RUSSIA
  • Table 26: Russia Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: Russia Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF EUROPE
  • Table 28: Rest of Europe Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 29: Rest of Europe Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ASIA-PACIFIC
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 30: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 31: Asia-Pacific Historic Review for Anti-Ischemic Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 32: Asia-Pacific 16-Year Perspective for Anti-Ischemic Agents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • Table 33: Australia Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 34: Australia Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
INDIA
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • Table 35: India Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: India Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SOUTH KOREA
  • Table 37: South Korea Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 38: South Korea Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF ASIA-PACIFIC
  • Table 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 40: Rest of Asia-Pacific Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
LATIN AMERICA
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • Table 41: Latin America Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 42: Latin America Historic Review for Anti-Ischemic Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: Latin America 16-Year Perspective for Anti-Ischemic Agents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
ARGENTINA
  • Table 44: Argentina Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Argentina Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
BRAZIL
  • Table 46: Brazil Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 47: Brazil Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
MEXICO
  • Table 48: Mexico Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 49: Mexico Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF LATIN AMERICA
  • Table 50: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Rest of Latin America Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
MIDDLE EAST
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • Table 52: Middle East Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 53: Middle East Historic Review for Anti-Ischemic Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 54: Middle East 16-Year Perspective for Anti-Ischemic Agents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
IRAN
  • Table 55: Iran Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 56: Iran Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ISRAEL
  • Table 57: Israel Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 58: Israel Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SAUDI ARABIA
  • Table 59: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: Saudi Arabia Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
UNITED ARAB EMIRATES
  • Table 61: UAE Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 62: UAE Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF MIDDLE EAST
  • Table 63: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 64: Rest of Middle East Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
AFRICA
  • Anti-Ischemic Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • Table 65: Africa Recent Past, Current & Future Analysis for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: Africa Historic Review for Anti-Ischemic Agents by Segment - Anti-Ischemic Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca
  • Actelion
  • Bayer AG
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Baxter, Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi

Table Information